BlackRock’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-614,712
Closed -$49.2M 5148
2016
Q4
$49.2M Sell
614,712
-72,200
-11% -$5.73M 0.07% 319
2016
Q3
$54.8M Buy
686,912
+8,273
+1% +$668K 0.08% 285
2016
Q2
$52.9M Sell
678,639
-92,679
-12% -$6.61M 0.08% 278
2016
Q1
$42.4M Sell
771,318
-130,850
-15% -$7.13M 0.07% 321
2015
Q4
$55.7M Buy
902,168
+9,002
+1% +$568K 0.08% 278
2015
Q3
$56.4M Buy
893,166
+27,453
+3% +$1.96M 0.09% 249
2015
Q2
$63.3M Sell
865,713
-122,601
-12% -$8.86M 0.09% 246
2015
Q1
$64.6M Sell
988,314
-174,022
-15% -$11.6M 0.09% 258
2014
Q4
$75.6M Sell
1,162,336
-131,124
-10% -$8.44M 0.11% 208
2014
Q3
$77.8M Sell
1,293,460
-39,881
-3% -$2.61M 0.11% 190
2014
Q2
$92.3M Sell
1,333,341
-204,776
-13% -$13.3M 0.14% 165
2014
Q1
$101M Buy
1,538,117
+845,608
+122% +$55M 0.16% 142
2013
Q4
$42.9M Buy
692,509
+144,063
+26% +$8.34M 0.07% 289
2013
Q3
$29.4M Buy
548,446
+11,856
+2% +$611K 0.06% 355
2013
Q2
$24.5M Buy
+536,590
New +$23.3M 0.05% 378

Other funds holding STJ

BlackRock's STJ Position: Q1 2017 in Review

BlackRock sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 614,712 shares — an estimated $49.2M sold.

BlackRock first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $101M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • BlackRock reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • BlackRock sold 614,712 St Jude Medical shares in Q1 2017, an estimated $49.2M.
  • BlackRock first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • BlackRock's St Jude Medical position peaked at $101M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on BlackRock's 13F filing for Q1 2017, filed 12 May 2017.